Global Single-use Bioreactor Market - Segmented by Product (Single-use Bioreactor Systems, Media Bags, Filtration Assemblies, and Other Products), Cell Type, Molecule Type, and Geography - Growth, Trends, and Forecast (2022 - 2030)

The Single-use Bioreactor Market is expected to register a growth rate of nearly 15.5% over the forecast period, 2018 to 2023. Single-use bioreactors, also known as disposable bioreactors, have now become an integral part of biotechnology manufacturing facilities. Continuous product innovation and increasing R&D expenditure in manufacturing technology act as key drivers in improving the overall process and providing high-quality products, and this facilitates the transition from stainless steel bioreactors to single-use bioreactors. Single-use bioreactors are comparatively safe, simple, and flexible. Thus, their usage is getting augmented. Advancements in film technologies, stirring mechanisms, bioreactor designs, and sensor systems have contributed to the increasing adoption of disposable reactors from the laboratory to commercial use, which further propels the growth of the market. Single-use bioreactors are gaining importance mostly in the planning of fast-track projects, by outdating extensive and complex cleaning and sterilization procedures.

Cost Effectiveness and Lower Downtime to Boost the Growth of the Single-use Bioreactor Market

Single-use bioreactors have significantly shorter downtimes, which increases efficiency and annual batch output. The capital investment needed is much lower for facilities with single use bioreactors, than those with conventional stainless steel bioreactors. Disposable bioreactors are much more cost-effective, especially for manufacturing orphan drugs in the pharmaceutical industry. Single-use bioreactors are anticipated to mainly dominate pre-commercial, i.e., small- to mid-scale R&D, for manufacturing of R&D and clinical supplies, as they help reduce the cost associated with cleaning, sterilization, and maintenance, as compared to steel-based bioreactor systems, while the latter continues to lead at the commercial level, i.e., large volumes of product manufacturing. Single-use systems are already overhauling stainless-steel-based bioreactors to a considerable extent, in terms of flexibility, by shortening set-up times and providing faster change from one product line to another.
Other factors contributing to the single-use bioreactor market are the rapid adoption of single-use technologies in the industry and the launch of new products.

High Regular Recurring Expenses to Limit the Growth of the Single-use Bioreactor Market

Although the overall maintenance cost is lower, in case of single-use bioreactors, new disposable equipment need to be purchased for every product run. Therefore, regular recurring expenses for single-use bioreactors become higher, as compared to stainless-steel equipment, which already have high upfront costs in terms of installation and maintenance.
Additionally, regulatory concerns and issues with meeting standards of good manufacturing practices are restraining the single-use bioreactor market.

Asia-Pacific Expected to Exhibit the Fastest Growth in the Single Use Bioreactor Market, over the Forecast Period

The Asia-Pacific single-use bioreactor market is anticipated to experience the fastest growth. Particularly, developing economies like India and China have high growth potential, owing to an increasing skill base and the growing adoption of innovative technologies. Asia-Pacific is also expected to witness robust growth in the future, with higher market penetration and collaboration activities of leading companies, in this region. Applikon Biotechnology, an established leader in the bioreactor industry, expects further growth by tapping into Asian markets. In March 2018, WuXi Biologics, a leading global biologics technology platform company, announced that it had selected 4,000 liter custom single-run disposable bioreactors from ABEC for its new commercial manufacturing facility in Wuxi city, Jiangsu, China, which is expected to result in higher productivity and significantly lower cost of goods for cell-culture-based biopharmaceuticals. This emerging trend in the biotechnology industry is likely to increase demand for single-use bioreactors in Asia-Pacific, which is projected to help the market in the region grow faster than the global average. With the increasing focus of Asian government on further encouraging the growth of local biotechnology companies by offering tax incentives, cheaper land, and direct investment, the market is anticipated to register the highest CAGR.

Key Developments in the Single-use Bioreactor Market

• Apr 2018: Pall Corporation launched ALLEGRO STR 50 single-use stirred tank bioreactors to offer flexible and easy seeding from a bench-top bioreactor.
• Mar 2018: Sartorius Stedim Biotech launched the AMBR 250 high-throughput bioreactor system for perfusion culture.

Major Players: CELLEXUS LTD, CELLTAINER, DISTEK INC., ESCO MICRO PTE LTD, EPPENDORF, GE HEALTHCARE, MERCK KGAA, OMNIBRX BIOTECHNOLOGIES, PALL CORPORATION, PBS BIOTECH INC., SARTORIUS AG, and THERMO FISHER SCIENTIFIC among others.

Reasons to Purchase this Report

• Current and future Single-use Bioreactor market outlook, for the developed and emerging markets
• Analysis of various perspectives on the market ,with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identifying the latest developments, market shares, and strategies employed by the major market players
• 3-month analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

• This report can be customized to meet your requirements. Please contact our representative, who will ensure that you get a report that suits your needs.

Frequently Asked Questions